Wow - if my kid was above that dotted line I'd be doing everything in my power to get them access to Rem-L - and I bet even the downrampers and naysayers on this forum would be doing exactly the same.
Ann: Remestemcel-L Improves Survival in High-Risk Acute GvHD, page-117
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.74%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | $1.03 | $1.262M | 1.216M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6077 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 65313 | 11 |
View Market Depth
| Last trade - 10.17am 30/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |